Machine Learning-Based Multiparametric Magnetic Resonance Imaging Radiomics for Prediction of H3K27M Mutation in

Sedat Giray Kandemirli1, Burak Kocak2, Shotaro Naganawa3

  • 1Department of Radiology, University of Iowa Hospital and Clinics, Iowa City, Iowa, USA.

World Neurosurgery
|April 5, 2021
PubMed
Abstract

Insights

Machine learning analysis of MRI scans can predict H3K27M mutations in midline gliomas. This noninvasive radiomic model shows promise for identifying these mutations, aiding in diagnosis and prognosis.

Area of Science:

  • Neuro-oncology
  • Radiology
  • Machine Learning

Background:

  • H3K27M mutations in gliomas have significant prognostic implications.
  • Previous MRI studies have shown variable imaging features in H3K27M-mutant gliomas, lacking distinct characteristics compared to wild-type gliomas.
  • Accurate prediction of H3K27M mutation status is crucial for guiding treatment and understanding disease progression.

Purpose of the Study:

  • To develop and validate a machine learning (ML)-based radiomic model using multiparametric MRI to predict H3K27M mutation status in midline gliomas.
  • To assess the noninvasive capability of radiomic analysis in differentiating H3K27M-mutant from wild-type midline gliomas.
  • To improve diagnostic accuracy for H3K27M mutations, which are critical for patient prognosis.

Main Methods:

  • A multi-institutional cohort of 109 patients (50 H3K27M-mutant, 59 wild-type) was analyzed.
  • Radiomic features were extracted from conventional MRI sequences (T1-weighted, T2-weighted, T2-FLAIR, postcontrast T1-weighted, ADC maps).
  • An extreme gradient boosting (XGBoost) algorithm was employed to build an ML model, with performance evaluated using the area under the receiver operating characteristic curve (AUC).

Main Results:

  • The XGBoost model, incorporating feature selection, achieved an AUC of 0.791 in the training set and 0.737 in the test set.
  • In the test set, the model demonstrated an accuracy of 72.7%, precision of 76.5%, recall of 72.2%, and F1-score of 74.3%.
  • The study included a significant proportion of pediatric patients (55%).

Conclusions:

  • ML-based radiomic analysis of multiparametric MRI is a promising noninvasive method for predicting H3K27M mutation status in midline gliomas.
  • This approach could aid in the early identification of H3K27M mutations, facilitating timely clinical management.
  • The findings support the integration of advanced imaging analysis techniques in the diagnostic pathway for brain tumors.